Talk to Robyn

00 1 718 213 49 04

Search inside this page

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics in Oceania Countries, September 2012 (p7)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

181-230 of about 400 reports
Chemical & Pharmaceutical Plant Construction in Australia to 2016: Market Databook

Chemical & Pharmaceutical Plant Construction in Australia to 2016: Market Databook

  • $ 500
  • Industry report
  • September 2012
  • by Timetric

Synopsis Timetric's 'Chemical & Pharmaceutical Plant Construction in Australia to 2016: Market Databook' contains detailed historic and forecast market value data for the chemical & pharmaceutical plants ...

  • Industries : Pharmaceutical
  • Countries : Australia
Antibiotics Market in Australia to 2016

Antibiotics Market in Australia to 2016

  • $ 652
  • Industry report
  • September 2012
  • by Global Research & Data Services

This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Australia. The study provides essential market information for decision-makers ...

  • Industries : Drug and Medication
  • Countries : Australia
MarketVIEW: Acne vaccines

MarketVIEW: Acne vaccines

  • $ 8 995
  • Industry report
  • September 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Acne vulgaris is a common skin condition which is estimated to affect 80% of people at some point between 11 and 30 years of age. The condition ranges from mild to severe with latter more likely to cause ...

  • Industries : Drug and Medication
  • Countries : United States, Australia, Canada, Spain, Italy, France, Germany, Japan
Bronchitis - Pipeline Review, H2 2012

Bronchitis - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • August 2012
  • by Global Markets Direct

Bronchitis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Bronchitis - Pipeline Review, H2 2012', provides an overview of the Bronchitis therapeutic pipeline. This report provides information ...

  • Industries : Pathology
  • Countries : Australia, World
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • August 2012
  • by Global Markets Direct

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012', provides an overview ...

  • Industries : Pathology
  • Countries : Australia
Disease and Therapy Review: Diabetes

Disease and Therapy Review: Diabetes

  • $ 995
  • Industry report
  • August 2012
  • by Timely Data Resources Inc.

Abstract The Diabetes Disease and Therapy Review provides an overview of Type 1 and Type 2 diabetes, with incidence and prevalence numbers for major countries worldwide, information on diagnosis, and an ...

  • Industries : Therapy
  • Countries : World, Canada, Spain, Italy, France, Germany, Japan, China, United States, Mexico, Philippines, India, Sudan, Asia, Europe, United Kingdom, Australia, Indonesia, South Africa, Africa, Chile, Vietnam, Thailand, Tanzania, Nigeria, North America
New Zealand Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

New Zealand Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 088
  • Industry report
  • August 2012
  • by Business Monitor International

BMI View: New Zealand's pharmaceutical industry has a classic low risk, low reward profile. Multinational drugmakers are attracted to the country's non-communicable disease burden, direct-toconsumer advertising ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
CBio Limited (CBZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CBio Limited (CBZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2012
  • by Global Data

CBio Limited (CBZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary CBio Limited ( CBio ) is a research focused biopharmaceutical company targeting on development of technologies fo ...

  • Industries : Pharmaceutical
  • Countries : Australia
Australia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Australia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 088
  • Industry report
  • August 2012
  • by Business Monitor International

BMI View: Australian prospects for multinational drugmakers are mixed. In the first quarter of the year it was announced that eight medicines would not be included in the country's Pharmaceutical Benefits ...

  • Industries : Pharmaceutical
  • Countries : Australia
Physiotherapy Services Market in Australia

Physiotherapy Services Market in Australia

  • $ 980
  • Industry report
  • July 2012
  • by Ibisworld

IBISWORLD This is the replacement for IBISWorld's October Physiotherapy Services in Australia About this Market This market research report from IBISWorld provides a in-depth overview of the Physiotherapy ...

  • Industries : Therapy
  • Countries : Australia
Sigma Pharmaceuticals Limited (SIP) : Company Profile and SWOT Analysis

Sigma Pharmaceuticals Limited (SIP) : Company Profile and SWOT Analysis

  • $ 120
  • Company report
  • July 2012
  • by World Market Intelligence Ltd

Synopsis World Market Intelligence's 'Sigma Pharmaceuticals Limited (SIP) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains ...

  • Industries : Pharmacies and Drug Stores
  • Countries : Australia
Vitamins and Provitamins - Australia

Vitamins and Provitamins - Australia

  • $ 652
  • Industry report
  • July 2012
  • by Global Research & Data Services

This market research report offers a perspective on the actual market situation, trends and future outlook for vitamins and provitamins in Australia. The study provides essential market information fo ...

  • Industries : Vitamin and Supplement
  • Countries : Australia
MarketVIEW: Candida vaccines

MarketVIEW: Candida vaccines

  • $ 7 995
  • Industry report
  • July 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Candida yeasts cause Candidiasis which is a fungal infection commonly found in humans. Infections can occur in the female Genital area "vulvovaginal candidiasis" of which nearly 75% of all adult women ...

  • Industries : Drug and Medication
  • Countries : Australia, Canada, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, World, Oceania
MarketVIEW: Herpes Simplex Virus vaccines (therapeutic)

MarketVIEW: Herpes Simplex Virus vaccines (therapeutic)

  • $ 8 995
  • Industry report
  • July 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Herpes Simplex Virus (HSV) is a sexually transmitted virus which is a major cause of genital herpes (GH). Although most individuals infected with HSV-2 have minimal signs of infection, the disease is ...

  • Industries : Drug and Medication
  • Countries : United States, United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, World
Australian Drug Sector: Sector Report

Australian Drug Sector: Sector Report

  • $ 800
  • Industry report
  • July 2012
  • by Daedal Research

This industry profile is an essential tool to help your company gain an in-depth knowledge and competitive advantage in the industry. The profile is an assimilation of insider knowledge, market characteristics ...

  • Industries : Drug and Medication
  • Countries : Australia
Australian Pharmaceutical Sector: Sector Report

Australian Pharmaceutical Sector: Sector Report

  • $ 800
  • Industry report
  • July 2012
  • by Daedal Research

This industry profile is an essential tool to help your company gain an in-depth knowledge and competitive advantage in the industry. The profile is an assimilation of insider knowledge, market characteristics ...

  • Industries : Pharmaceutical
  • Countries : Australia
Disease and Therapy Review: Heart Failure

Disease and Therapy Review: Heart Failure

  • $ 995
  • Industry report
  • June 2012
  • by Timely Data Resources Inc.

Abstract The Heart Failure Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers and percentages for major countries worldwide, ...

  • Industries : Therapy
  • Countries : World, Spain, France, China, United States, United Kingdom, Australia, Netherlands, Europe, Italy, Germany, Thailand, Japan, India
Kawasaki Disease - Pipeline Review, H1 2012

Kawasaki Disease - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • June 2012
  • by Global Markets Direct

Kawasaki Disease - Pipeline Review, H1 2012 Summary Global Markets Direct's, 'Kawasaki Disease - Pipeline Review, H1 2012', provides an overview of the Kawasaki Disease therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : World, Australia
Disease and Therapy Review: Breast Cancer

Disease and Therapy Review: Breast Cancer

  • $ 995
  • Industry report
  • June 2012
  • by Timely Data Resources Inc.

Abstract The Breast Cancer Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence and mortality numbers and percentages for major countries worldwide, ...

  • Industries : Therapy
  • Countries : World, Russian Federation, Philippines, Argentina, South Africa, Europe, Brazil, Mexico, Canada, Spain, Poland, Italy, Greece, France, Germany, Thailand, South Korea, Japan, India, China, Egypt, Australia, Asia, Sweden, Africa, United States, United Kingdom, South America, North America, Oceania
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2012

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • June 2012
  • by Global Markets Direct

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2012 Summary Global Markets Direct's, 'Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2012', provides an overview ...

  • Industries : Pathology
  • Countries : World, Australia
Mylan Inc. (MYL) : Company Profile and SWOT Analysis

Mylan Inc. (MYL) : Company Profile and SWOT Analysis

  • $ 120
  • Company report
  • June 2012
  • by World Market Intelligence Ltd

Synopsis World Market Intelligence's 'Mylan Inc. (MYL) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, ...

  • Industries : Drug Delivery Technology
  • Countries : United States, World, New Zealand, Australia, Canada, Japan, India
Genzyme Corporation (GENZ) : Company Profile and SWOT Analysis

Genzyme Corporation (GENZ) : Company Profile and SWOT Analysis

  • $ 120
  • Company report
  • June 2012
  • by World Market Intelligence Ltd

Synopsis World Market Intelligence's 'Genzyme Corporation (GENZ) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a ...

  • Industries : Pathology
  • Countries : United States, World, Australia
Biogen Idec Inc. (BIIB) : Company Profile and SWOT Analysis

Biogen Idec Inc. (BIIB) : Company Profile and SWOT Analysis

  • $ 120
  • Company report
  • June 2012
  • by World Market Intelligence Ltd

Synopsis World Market Intelligence's 'Biogen Idec Inc. (BIIB) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company ...

  • Industries : Pathology
  • Countries : United States, World, Australia, Canada, Japan
Biotrin International - Product Pipeline Analysis

Biotrin International - Product Pipeline Analysis

  • $ 750
  • Company report
  • June 2012
  • by Global Data

Biotrin International - Product Pipeline Analysis Summary Biotrin International (Biotrin) is a medical device company, based in Ireland. The company provides novel and proprietary tests for the clinician ...

  • Industries : Pathology
  • Countries : Czech Republic, Ireland, World, Australia, Argentina, Europe
MarketVIEW: Chlamydia trachomatis vaccines

MarketVIEW: Chlamydia trachomatis vaccines

  • $ 8 995
  • Industry report
  • June 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Chlamydia trachomatis (CT) is an intracellular Gram-negative bacterium and a leading cause worldwide of sexually-transmitted disease and preventable blindness. The pathogen is a major cause of serious ...

  • Industries : Drug and Medication
  • Countries : Australia, World, Brazil, United States, Mexico, Canada, United Kingdom, Spain, Russian Federation, Italy, France, Germany, Japan, India, China, Europe
Australian Drug Market Research

Australian Drug Market Research

  • $ 600
  • Industry report
  • June 2012
  • by Koncept Analytics

This market profile helps to gain an insight into the evolution of the market and competitive dynamics prevalent in the industry . It discusses the significant developments in the market and analyzes the ...

  • Industries : Drug and Medication
  • Countries : Australia
Asia Pacific Pharma Sector Analysis

Asia Pacific Pharma Sector Analysis

  • $ 1 300
  • Industry report
  • June 2012
  • by RNCOS

The Asia-Pacific region is emerging as the fastest growing pharmaceutical industry in the global pharmaceutical arena. In the recent years, the demand for healthcare services has risen among the region's ...

  • Industries : Generic Drug
  • Countries : Asia, Philippines, South Korea, Australia, India, China, World, Thailand, Malaysia, Japan, New Zealand, Indonesia, Vietnam, Oceania
Australian Pharmaceutical Market Research

Australian Pharmaceutical Market Research

  • $ 600
  • Industry report
  • June 2012
  • by Koncept Analytics

This market profile helps to gain an insight into the evolution of the market and competitive dynamics prevalent in the industry . It discusses the significant developments in the market and analyzes the ...

  • Industries : Pharmaceutical
  • Countries : Australia
Chronic Obstructive Pulmonary Disease (COPD) - Executive Market Summary 2011

Chronic Obstructive Pulmonary Disease (COPD) - Executive Market Summary 2011

  • $ 995
  • Industry report
  • May 2012
  • by Timely Data Resources Inc.

Abstract The Chronic Obstructive Pulmonary Disease (COPD) Executive Market Summary 2011 provides an overview of the disease and related conditions, with prevalence and mortality numbers and percentages ...

  • Industries : Pathology
  • Countries : World, Europe, France, China, Australia, United States, Mexico, Canada, United Kingdom, Sweden, Spain, Russian Federation, Romania, Poland, Italy, Greece, Germany, Japan, India
Ulcerative Colitis - Executive Market Summary 2011

Ulcerative Colitis - Executive Market Summary 2011

  • $ 995
  • Industry report
  • May 2012
  • by Timely Data Resources Inc.

Abstract The Ulcerative Colitis Executive Market Summary 2011 provides an overview of the disease and related conditions, with incidence prevalence information for major countries worldwide, information ...

  • Industries : Pathology
  • Countries : South Korea, World, Canada, Italy, Japan, Europe, North America, Australia, Singapore, United States, United Kingdom, Spain, France, Germany, China, Asia

» Download Public Reports

About 1 500 reports
Australia: Demographic Analysis, 2013

Australia: Demographic Analysis, 2013

  • Country report
  • May 2013
  • 20 pages

... In screening for breast cancer is higher than the victorian average while cervical cancer and bowel cancer screening rates are slightly lower. 9 Health status all gippsland lgas regions score higher than ...


» Read our Company Profiles

12 Companies

GlaxoSmithKline P.L.C.

United States

Management Strategies

United States

Abbott Laboratories

United States

Johnson and Johnson

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.